Abstract | OBJECTIVE: METHODS: A task force was assembled that included 9 rheumatologists/immunologists, 2 infectious diseases specialists, and 2 public health physicians. After agreeing on scoping questions, an evidence report was created that summarized the published literature and publicly available data regarding COVID-19 vaccine efficacy and safety, as well as literature for other vaccines in RMD patients. Task force members rated their agreement with draft consensus statements on a 9-point numerical scoring system, using a modified Delphi process and the RAND/University of California Los Angeles Appropriateness Method, with refinement and iteration over 2 sessions. Consensus was determined based on the distribution of ratings. RESULTS: Despite a paucity of direct evidence, statements were developed by the task force and agreed upon with consensus to provide guidance for use of the COVID-19 vaccines, including supplemental/booster dosing, in RMD patients and to offer recommendations regarding the use and timing of immunomodulatory therapies around the time of vaccination. CONCLUSION: These guidance statements are intended to provide direction to rheumatology health care providers on how to best use COVID-19 vaccines and to facilitate implementation of vaccination strategies for RMD patients.
|
Authors | Jeffrey R Curtis, Sindhu R Johnson, Donald D Anthony, Reuben J Arasaratnam, Lindsey R Baden, Anne R Bass, Cassandra Calabrese, Ellen M Gravallese, Rafael Harpaz, Andrew Kroger, Rebecca E Sadun, Amy S Turner, Eleanor Anderson Williams, Ted R Mikuls |
Journal | Arthritis & rheumatology (Hoboken, N.J.)
(Arthritis Rheumatol)
Vol. 75
Issue 1
Pg. E1-E16
(01 2023)
ISSN: 2326-5205 [Electronic] United States |
PMID | 36345691
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Copyright | © 2022 American College of Rheumatology. |
Chemical References |
|
Topics |
- Humans
- United States
- Rheumatology
- COVID-19 Vaccines
(therapeutic use)
- Rheumatic Diseases
(drug therapy)
- COVID-19
(prevention & control)
- Musculoskeletal Diseases
- Vaccination
|